Kelly Sheehan

1.1k total citations
16 papers, 919 citations indexed

About

Kelly Sheehan is a scholar working on Sensory Systems, Neurology and Molecular Biology. According to data from OpenAlex, Kelly Sheehan has authored 16 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Sensory Systems, 7 papers in Neurology and 3 papers in Molecular Biology. Recurrent topics in Kelly Sheehan's work include Hearing, Cochlea, Tinnitus, Genetics (12 papers), Vestibular and auditory disorders (7 papers) and Ion Channels and Receptors (4 papers). Kelly Sheehan is often cited by papers focused on Hearing, Cochlea, Tinnitus, Genetics (12 papers), Vestibular and auditory disorders (7 papers) and Ion Channels and Receptors (4 papers). Kelly Sheehan collaborates with scholars based in United States. Kelly Sheehan's co-authors include Vickram Ramkumar, Leonard P. Rybak, Debashree Mukherjea, Tejbeer Kaur, Sarvesh Jajoo, Sandeep Sheth, Vikrant Borse, Sumana Ghosh, Srinivasan Tupal and Asmita Dhukhwa and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Scientific Reports.

In The Last Decade

Kelly Sheehan

16 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Sheehan United States 12 434 340 173 141 105 16 919
Sarvesh Jajoo United States 15 575 1.3× 511 1.5× 206 1.2× 216 1.5× 194 1.8× 17 1.4k
Xiang Huang China 18 99 0.2× 540 1.6× 246 1.4× 58 0.4× 68 0.6× 42 902
Xiaoyun Chen China 16 138 0.3× 350 1.0× 109 0.6× 50 0.4× 63 0.6× 32 691
Anna Scotto Rosato Germany 11 237 0.5× 554 1.6× 40 0.2× 26 0.2× 22 0.2× 12 1.6k
Keum‐Jin Yang South Korea 18 93 0.2× 365 1.1× 75 0.4× 91 0.6× 30 0.3× 36 717
Yingpei Zhang United States 14 82 0.2× 380 1.1× 48 0.3× 28 0.2× 24 0.2× 36 731
Cristina Goso Italy 19 197 0.5× 484 1.4× 41 0.2× 22 0.2× 202 1.9× 38 1.0k
Sihan Li United States 13 86 0.2× 329 1.0× 115 0.7× 71 0.5× 55 0.5× 25 631
Akın Yılmaz Türkiye 17 87 0.2× 299 0.9× 79 0.5× 51 0.4× 91 0.9× 50 842
Robert P. Meech United States 11 570 1.3× 172 0.5× 11 0.1× 211 1.5× 104 1.0× 14 830

Countries citing papers authored by Kelly Sheehan

Since Specialization
Citations

This map shows the geographic impact of Kelly Sheehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Sheehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Sheehan more than expected).

Fields of papers citing papers by Kelly Sheehan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Sheehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Sheehan. The network helps show where Kelly Sheehan may publish in the future.

Co-authorship network of co-authors of Kelly Sheehan

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Sheehan. A scholar is included among the top collaborators of Kelly Sheehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Sheehan. Kelly Sheehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sheth, Sandeep, Kelly Sheehan, Asmita Dhukhwa, et al.. (2019). Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss. Scientific Reports. 9(1). 9571–9571. 14 indexed citations
2.
Dhukhwa, Asmita, Kelly Sheehan, Vikrant Borse, et al.. (2019). Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea. Scientific Reports. 9(1). 4131–4131. 39 indexed citations
3.
Ghosh, Sumana, Sandeep Sheth, Kelly Sheehan, et al.. (2018). The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss. Frontiers in Cellular Neuroscience. 12. 271–271. 38 indexed citations
4.
Sheehan, Kelly, Sandeep Sheth, Debashree Mukherjea, Leonard P. Rybak, & Vickram Ramkumar. (2018). Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity. Journal of Visualized Experiments. 10 indexed citations
5.
Sheehan, Kelly, Sandeep Sheth, Debashree Mukherjea, Leonard P. Rybak, & Vickram Ramkumar. (2018). Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity. Journal of Visualized Experiments. 1 indexed citations
6.
Borse, Vikrant, Kelly Sheehan, Sandeep Sheth, et al.. (2017). Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity. Cell Death and Disease. 8(7). e2921–e2921. 89 indexed citations
7.
Kaur, Tejbeer, Vikrant Borse, Sandeep Sheth, et al.. (2016). Adenosine A1Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea. Journal of Neuroscience. 36(14). 3962–3977. 91 indexed citations
8.
Mukherjea, Debashree, Sumana Ghosh, Sandeep Sheth, et al.. (2014). Early investigational drugs for hearing loss. Expert Opinion on Investigational Drugs. 24(2). 201–217. 22 indexed citations
9.
Jajoo, Sarvesh, Debashree Mukherjea, Tejbeer Kaur, et al.. (2013). Essential Role of NADPH Oxidase-Dependent Reactive Oxygen Species Generation in Regulating MicroRNA-21 Expression and Function in Prostate Cancer. Antioxidants and Redox Signaling. 19(16). 1863–1876. 51 indexed citations
10.
Sheth, Sandeep, Sarvesh Jajoo, Tejbeer Kaur, et al.. (2012). Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway. PLoS ONE. 7(12). e51655–e51655. 180 indexed citations
11.
Mukherjea, Debashree, Leonard P. Rybak, Kelly Sheehan, et al.. (2011). The design and screening of drugs to prevent acquired sensorineural hearing loss. Expert Opinion on Drug Discovery. 6(5). 491–505. 52 indexed citations
12.
Kaur, Tejbeer, Debashree Mukherjea, Kelly Sheehan, et al.. (2011). Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation. Cell Death and Disease. 2(7). e180–e180. 125 indexed citations
13.
Mukherjea, Debashree, Sarvesh Jajoo, Kelly Sheehan, et al.. (2010). NOX3 NADPH Oxidase Couples Transient Receptor Potential Vanilloid 1 to Signal Transducer and Activator of Transcription 1-Mediated Inflammation and Hearing Loss. Antioxidants and Redox Signaling. 14(6). 999–1010. 81 indexed citations
14.
Mukherjea, Debashree, Sarvesh Jajoo, Tejbeer Kaur, et al.. (2010). Transtympanic Administration of Short Interfering (si)RNA for the NOX3 Isoform of NADPH Oxidase Protects Against Cisplatin-Induced Hearing Loss in the Rat. Antioxidants and Redox Signaling. 13(5). 589–598. 120 indexed citations
15.
Beran, Roy G. & Kelly Sheehan. (1996). An appraisal of the clinical use of lamotrigine under the special access scheme. Journal of Clinical Neuroscience. 3(3). 239–242. 4 indexed citations
16.
Beran, Roy G., et al.. (1994). Routine use of lamotrigine, a new anti-epileptic medication, and the value of measuring its blood levels.. PubMed. 31. 61–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026